VBI-1901
N/A
Report date: 2026/05/09 20:00:18
Base Information
Drug NameVBI-1901
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVbi Vaccines Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesVbi Vaccines IncBrii Biosciences Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A